MedPath

A study to compare the effects on Sugar control via WhatsApp based Insulin education among diabetes patients using Insulin.

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: E10- Type 1 diabetes mellitusHealth Condition 2: E11- Type 2 diabetes mellitus
Registration Number
CTRI/2024/07/070349
Lead Sponsor
AIIMS Kalyani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All consecutive patients attending the Endocrinology and Metabolism Outpatient Department of AIIMS, Kalyani, with a known history of Diabetes Mellitus who are on insulin therapy for minimum span of 3 months.

2.Age group: 30-50 yrs

3.BMI: 23-30 kg/m2

4.Patients having HbA1c level: 7.5-12.5%

5.Patients receiving Insulin at least twice a day

6.Patients who has access to WhatsApp.

Exclusion Criteria

1.Patients with known psychiatric illness and/or currently on psychiatry medications.

2.Any underlying Endocrinological disorder causing secondary diabetes mellitus such as Cushing’s disease, Acromegaly, Hyperthyroidism, type 3c diabetes.

3.Patients having secondary diabetes related to drugs like steroids, chemotherapy etc.

4.Pregnant and lactating mother up to 6 months, patients suffering from cancer and/or had a history of radiation or chemotherapy

5.DM Patients with CLD, CKD, eGFR less than 15, heart failure, any hematological disorder like beta-thalassemia etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath